Friday, June 9, 2017

=Collegium Pharmaceutical (COLL)


  • COLL will present data on Xtampza ER, an extended-release oral formulation of oxycodone with abuse-deterrent properties, at the 2017 International Conference on June 11-12;
  • Also reacts to Opana ER news

No comments:

Post a Comment